About the Journal

Aim of the Journal

The aim of the ACS Journal of Experimental and Clinical Pharmacology is to promote and disseminate impactful research in experimental and clinical pharmacology, supporting innovations in drug discovery, therapeutic evaluation, and rational pharmacotherapy for improved human health.

Scope of the Journal (Aim & Scope)

The journal publishes research and scholarly work in the following areas (but not limited to):

1.      Experimental pharmacology and preclinical drug evaluation

2.      Clinical pharmacology and clinical trial studies (Phase I–IV)

3.      Pharmacokinetics (PK), pharmacodynamics (PD), and PK/PD modeling

4.      Drug safety, adverse drug reactions (ADR), and pharmacovigilance

5.      Toxicology studies and safety assessment of drugs/chemicals

6.      Pharmacogenomics and personalized/precision medicine

7.      Drug interactions, contraindications, and therapeutic drug monitoring

8.      Molecular pharmacology, receptor pharmacology, and signal transduction

9.      Translational pharmacology and bench-to-bedside research

10.  Novel drug delivery systems and formulation-based pharmacology

11.  Natural products, herbal drugs, and bioactive compounds (scientific validation)

12.  Antimicrobial, anticancer, cardiovascular, neurological, and endocrine pharmacology

13.  Pharmacoeconomics, pharmacoepidemiology, and real-world evidence studies

14.  Clinical case studies with pharmacological significance

15.  Regulatory pharmacology, ethics, and guidelines related to drug use and trials